Novel mechanism offers hope for improved tolerability and efficacy in patients facing resistance or long-term toxicity with existing TKIs.
Andrea Clarke, PharmD, BCOP
Advertisement
Articles by Andrea Clarke, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
3
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
4
Current and Emerging BCMAxCD3 Bispecifics
5
